arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

BIO KEY INTERNATIONAL INC

BKYI
$4.07 ▼ -0.01 (-0.25%) at close
Technology ·Services-Prepackaged Software ·USServices-Prepackaged Software
17 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
11
Health
Poor
Bearish
auto_awesome

Analytical Summary

BIO KEY INTERNATIONAL INC faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.7M
Dividend Yield
Revenue Growth -14.3%
Op. Margin -115.0%
ROIC -134.0%
FCF / Share $-7.04
Trailing P/E
Price / Book 0.9x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$5.94M
↓ -14.3%
Net Income Profit after all expenses
$-7.16M
↓ -66.4%
Operating Margin Operating profit as % of sales
-115.0%
↓ -98.7% 2th
FCF / Share Free cash flow per share
$-7.04
↓ -395.5%
Long-Term Debt Long-term obligations
$44.76K
↓ -76.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
2
Returns
6
Financial Health
13
Cash Quality
46

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 66 quarters